BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35003744)

  • 1. Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results.
    Miyake R; Yamada Y; Yamanaka S; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
    Mol Clin Oncol; 2022 Feb; 16(2):46. PubMed ID: 35003744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
    Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer.
    Maehana T; Kawaguchi R; Nishikawa K; Kawahara N; Yamada Y; Kimura F
    Oncol Lett; 2024 Jul; 28(1):302. PubMed ID: 38774455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
    Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
    PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tissue factor pathway inhibitor 2 in the coagulation and fibrinolysis system.
    Kobayashi H; Matsubara S; Imanaka S
    J Obstet Gynaecol Res; 2023 Jul; 49(7):1677-1683. PubMed ID: 37186495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma.
    Arakawa N; Miyagi E; Nomura A; Morita E; Ino Y; Ohtake N; Miyagi Y; Hirahara F; Hirano H
    J Proteome Res; 2013 Oct; 12(10):4340-50. PubMed ID: 23805888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.
    Curtin N; Highe G; Harris M; Braunstein A; Demattia F; Coss L
    Lab Hematol; 2004; 10(2):88-94. PubMed ID: 15224764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
    Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
    Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.
    Cheng Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Zhang W; Wu J
    Clin Appl Thromb Hemost; 2019; 25():1076029619877458. PubMed ID: 31608652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Elevated D-Dimer Level in Venous Thromboembolism in Patients With Acute or Subacute Brain Lesions.
    Kim YJ; Im S; Jang YJ; Park SY; Sohn DG; Park GY
    Ann Rehabil Med; 2015 Dec; 39(6):1002-10. PubMed ID: 26798616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
    Wang Y; Zhou H; Zhong G; Fu Z; Peng Y; Yao T
    Clin Appl Thromb Hemost; 2022; 28():10760296221095558. PubMed ID: 35549519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a D-Dimer Protocol for Detection of Venous Thromboembolism.
    Karsy M; Azab MA; Harper J; Abou-Al-Shaar H; Guan J; Eli I; Brock AA; Ormond RD; Hosokawa PW; Gouripeddi R; Butcher R; Cole CD; Menacho ST; Couldwell WT
    World Neurosurg; 2020 Jan; 133():e774-e783. PubMed ID: 31605841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
    Kawaguchi R; Maehana T; Sugimoto S; Kawahara N; Iwai K; Yamada Y; Kimura F
    Int J Gynecol Pathol; 2024 Jan; 43(1):25-32. PubMed ID: 37255450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application value of D-dimer testing and Caprini risk assessment model (RAM) to predict venous thromboembolism (VTE) in Chinese non-oncological urological inpatients: a retrospective study from a tertiary hospital.
    Wu ZQ; Li KX; Zhu Q; Li HZ; Tang ZY; Wang Z
    Transl Androl Urol; 2020 Oct; 9(5):1904-1911. PubMed ID: 33209654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
    Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
    Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.
    Miyagi E; Arakawa N; Sakamaki K; Yokota NR; Yamanaka T; Yamada Y; Yamaguchi S; Nagao S; Hirashima Y; Kasamatsu Y; Kato H; Mogami T; Miyagi Y; Kobayashi H
    Int J Clin Oncol; 2021 Jul; 26(7):1336-1344. PubMed ID: 34009487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Multicenter Observational Study of Venous Thromboembolism after Gastric Cancer Surgery (SHISA-1601).
    Kaida S; Miyake T; Murata S; Yamaguchi T; Tatsuta T; Murakami K; Okauchi H; Nishimura S; Ohta H; Tsuchihashi H; Kawasaki M; Takebayashi K; Shimizu T; Tani M
    Eur Surg Res; 2021; 62(1):10-17. PubMed ID: 33657552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Dimer Combined with Fibrinogen Predicts the Risk of Venous Thrombosis in Fracture Patients.
    Lin C; Chen Y; Chen B; Zheng K; Luo X; Lin F
    Emerg Med Int; 2020; 2020():1930405. PubMed ID: 33029403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of biomarker D-dimer in patients after stroke suspected from venous thromboembolism: A diagnostic meta-analysis.
    Zhang D; Li F; Du X; Zhang X; Zhang Z; Zhao W; Du G
    Clin Biochem; 2019 Jan; 63():126-134. PubMed ID: 30261183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.